Showing results (1-10 of 27) with videos related to
Sort By:
Pageof 3
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 5, 2014
Aldosterone synthase inhibitors in cardiovascular and renal diseasesPawel Namsolleck, Thomas UngerMolecular Medicine (Cambridge, Mass.)|August 19, 2020
Does activation of the protective Renin-Angiotensin System have therapeutic potential in COVID-19?Pawel Namsolleck, Gert N MollPharmacological Research|July 12, 2017
AT2 receptors in cardiovascular and renal diseasesElena Kaschina, Pawel Namsolleck, Thomas UngerInternational Journal of Molecular Sciences|June 28, 2023
Galanin 2 Receptor: A Novel Target for a Subset of Pancreatic Ductal AdenocarcinomaPawel Namsolleck, Barbara Kofler, Gert N MollJournal of Microscopy|July 20, 2007
Centrifugation of bacterial cells on slide surface improves the spatial distribution, cell recovery and reduces the time of enumeration for fluorescence in situ hybridizationPawel Namsolleck, Ruchika Mohan, Corinna Koebnick, et al.Peptides|November 30, 2020
LP2, the first lanthipeptide GPCR agonist in a human pharmacokinetics and safety studyPawel Namsolleck, Alan Richardson, Gert N Moll, et al.Current Opinion in Nephrology and Hypertension|January 20, 2012
AT2 receptor agonists: hypertension and beyondUlrike M Steckelings, Ludovit Paulis, Pawel Namsolleck, et al.Peptides|September 24, 2023
AT2 receptor agonist LP2 restores respiratory function in a rat model of bleomycin-induced lung remodellingDaniel Campos Villela, Pawel Namsolleck, Christoph Reichetzeder, et al.AAPS Pharmscitech|June 17, 2004
Solubilizing poorly soluble antimycotic agents by emulsification via a solvent-free processAslihan Akkar, Pawel Namsolleck, Michael Blaut, et al.Current Hypertension Reports|January 14, 2014
AT(2) receptor and tissue injury: therapeutic implicationsPawel Namsolleck, Chiara Recarti, Sébastien Foulquier, et al.Pageof 3